Literature DB >> 2431430

The effect of midazolam and beta-carboline carboxylic acid ethyl ester on behaviour, steroid hormones and central monoamine metabolites in social groups of talapoin monkeys.

S V Vellucci, J Herbert, E B Keverne.   

Abstract

Established social groups of talapoin monkeys show rank-related differences in aggressive, social and sexual behaviours and visual monitoring, as well as in endocrine and monoamine profiles. Here we describe the effects on these variables of an "anxiogenic drug", beta-carboline carboxylic acid ethyl ester (beta-CCE), and an anxiolytic drug (midazolam) given to either dominant or subordinate male talapoins. In dominant animals beta-CCE increased aggression and visual monitoring but reduced sexual behaviour. Treatment of subordinate animals with beta-CCE served only to increase visual monitoring. Conversely, treatment with a non-sedative acute dose of midazolam in dominants reduced aggressive behaviour and increased sexual behaviour, whereas in subordinates no behavioural changes were noted. Significant effects on endocrine and neurochemical variables were not seen with the acute drug treatments employed. Nevertheless, the results show that drugs which modulate anxiety produce status-dependent behavioural effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431430     DOI: 10.1007/bf00179193

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Metrazol tolerance in a normal voluntser population; an investigation of the potential significance of abnormal findings.

Authors:  E RODIN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1958-08

2.  Clinical, electroencephalographic, and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate.

Authors:  C R Brown; F H Sarnquist; C A Canup; T A Pedley
Journal:  Anesthesiology       Date:  1979-05       Impact factor: 7.892

3.  The proconvulsant and diazepam-reversing effects of ethyl-beta-carboline-3-carboxylate.

Authors:  N R Oakley; B J Jones
Journal:  Eur J Pharmacol       Date:  1980-12-05       Impact factor: 4.432

4.  A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies.

Authors:  R F Schlemmer; J M Davis
Journal:  Prog Clin Biol Res       Date:  1983

Review 5.  Pharmacology of midazolam.

Authors:  L Pieri; R Schaffner; R Scherschlicht; P Polc; J Sepinwall; A Davidson; H Möhler; R Cumin; M Da Prada; W P Burkard; H H Keller; R K Müller; M Gerold; M Pieri; L Cook; W Haefely
Journal:  Arzneimittelforschung       Date:  1981

6.  Benzodiazepine receptor-mediated experimental "anxiety" in primates.

Authors:  P T Ninan; T M Insel; R M Cohen; J M Cook; P Skolnick; S M Paul
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

7.  Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction.

Authors:  M Nielsen; C Braestrup
Journal:  Nature       Date:  1980-08-07       Impact factor: 49.962

8.  Peripheral metabolism of beta-carboline-carboxylic acid esters.

Authors:  H Simonsen; M Nielsen; C Braestrup
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-02

9.  Modification of diazepam's antileptazol activity by endogenous tryptophan-like compounds.

Authors:  S V Vellucci; R A Webster
Journal:  Eur J Pharmacol       Date:  1981-12-03       Impact factor: 4.432

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  2 in total

1.  Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.

Authors:  Karen Pazol; Mark E Wilson; Kim Wallen
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Rearing paradigm in a nonhuman primate affects response to beta-CCE challenge.

Authors:  T R Insel; J Scanlan; M Champoux; S J Suomi
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.